Sanwa Kagaku Kenkyusho Co., Ltd.
Quick facts
| Founded | 1953 |
|---|
Marketed products
Phase 3 pipeline
- SK-1403 · Unknown
SK-1403 is a small molecule drug that targets the molecular target.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Sanwa Kagaku Kenkyusho Co., Ltd. portfolio CI brief
- Sanwa Kagaku Kenkyusho Co., Ltd. pipeline updates RSS
Frequently asked questions about Sanwa Kagaku Kenkyusho Co., Ltd.
What are Sanwa Kagaku Kenkyusho Co., Ltd.'s marketed drugs?
Top marketed products include Cephulac, Upasita.
What is Sanwa Kagaku Kenkyusho Co., Ltd.'s pipeline?
Sanwa Kagaku Kenkyusho Co., Ltd. has 1 drugs in Phase 3, 4 in Phase 2, 3 in Phase 1. Late-stage candidates include SK-1403.
When was Sanwa Kagaku Kenkyusho Co., Ltd. founded?
Sanwa Kagaku Kenkyusho Co., Ltd. was founded in 1953.
Related
- Cephulac · Infectious Disease
- Upasita · Hematology
- Sector hub: All tracked pharma companies